Work

The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy

Year: 2013

Type: review

Source: Current Opinion in Immunology

DOI: 10.1016/j.coi.2013.01.004

Authors: Amy E Moran, Magdalena Kovacsovics-Bankowski, Andrew D Weinberg

Institution: Providence Portland Medical Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: G3478249038, G5217986970, G5631452654, G5780489950, G6613445966, Inflammation and T Lymphocyte Immunoregulation

OpenAlex ID: W2012826189

FWCI: 1.073

Cites: 67

Cited by: 162

Related to: 10